Certified by Founder Lodge
Cyrano Therapeutics

START UP
1 Disclosed Funding Rounds $9,000,000
0 Participating Investments
- Founded date
2014
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 milli
Date | Round | Raised | Participating Investors |
---|---|---|---|
January, 17 ,2024 | Series B | $9,000,000 |